Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Elijah Kahn-Woods"'
Autor:
Katerina Chapman, Sergio Torres-Rueda, Mutsumi Metzler, Bethany Young Holt, Elijah Kahn-Woods, Douglas Thornton, Gabriela B. Gomez
Publikováno v:
Frontiers in Reproductive Health, Vol 6 (2024)
Product development is a high-risk undertaking, especially so when investments are prioritized for low- and middle-income countries (LMICs) where markets may be smaller, fragile, and resource-constrained. New HIV prevention technologies, such as the
Externí odkaz:
https://doaj.org/article/3e72e94c49e24298a3763a97effab3a2
Publikováno v:
HIV/AIDS Research and Treatment – Open Journal. 7:5-9
Monitoring adherence to pre-exposure prophylaxis is a critical component of reaching ending the human immunodeficiency virus infection (HIV) epidemic goals in the US. Currently, providers still depend on “self-report” pre-exposure prophylaxis (Pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::343ae613a30fbeb8d544e2b0a835e27b
https://doi.org/10.17140/hartoj-7-133
https://doi.org/10.17140/hartoj-7-133
Autor:
Whitney Engeran, Lupita Thornton, Shane Hebel, Giffin W. Daughtridge, Marlene McNeese, Sheryl Malone-Thomas, Elijah Kahn-Woods, Adam Sukhija-Cohen, Henna Patani
Publikováno v:
Journal of acquired immune deficiency syndromes (1999). 85(4)
Background Pre-exposure prophylaxis (PrEP) is only effective in preventing new HIV infections when taken consistently. In clinical practice, asking a patient about their adherence (self-report) is the predominant method of assessing adherence to PrEP
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56861153cb7c55c424b3c3e2c4c23236
https://pubmed.ncbi.nlm.nih.gov/33136744
https://pubmed.ncbi.nlm.nih.gov/33136744
Autor:
Elijah Kahn-Woods, Giffin W. Daughtridge, Helen C. Koenig, Asa Radix, Linden Lalley-Chareczko, Shane Hebel, Casper Enghuus
Publikováno v:
Open Forum Infectious Diseases
Background HIV pre-exposure prophylaxis (PrEP) is 99% effective at preventing new HIV infections if taken daily. To be successful, PrEP requires concurrent efforts to optimize uptake, persistence, and adherence. In 2018, cisgender (cis) women account
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::536132f45442778740402fb4dfadaa49
http://europepmc.org/articles/PMC7776913
http://europepmc.org/articles/PMC7776913